Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia
Janneke W. C. M. Mulder,Tycho R. Tromp,Mutaz Al-Khnifsawi,Dirk J. Blom,Krysztof Chlebus,Marina Cuchel,Laura D’Erasmo,Antonio Gallo,G. Kees Hovingh,Ngoc Thanh Kim,Jiang Long,Frederick J. Raal,Willemijn A. M. Schonck,Handrean Soran,Thanh-Huong Truong,Eric Boersma,Jeanine E. Roeters van Lennep,Mohammed D. Alareedh,Rano Alieva,Massimiliano Allevi,Bulent B. Altunkeser,Khalid Al-Waili,Ali F. Al-Zamili,Marcello Arca,Luigi Atzori,Maurizio Averna,Mahmoud H. Ayesh,Sami T. Azar,Giuseppe Banderali,Francesco Baratta,Andrea Bartuli,Sophie Béliard,Vanessa Bianconi,Simone Bini,Khalid Bin Thani,Fadi F. Bitar,Vladimir Blaha,Katia Bonomo,Mafalda Bourbon,Adriana Branchi,Julie A. Brothers,Eric Bruckert,Liam R. Brunham,Patrizia Bruzzi,Marco Bucci,Paola S. Buonuomo,Paolo Calabrò,Sebastiano Calandra,Francesca Carubbi,David Cassiman,Manuela Casula,Alberico L. Catapano,Franco Cavalot,Angelo B. Cefalù,Arturo Cesaro,Richard Ceska,Min-Ji Charng,Francesco Cipollone,Hofit Cohen,Sergio D'Addato,Beatrice Dal Pino,Eldad J. Dann,Joep C. Defesche,Maria Del Ben,Sinan Demircioglu,Olivier S. Descamps,Alessia Di Costanzo,Maria D. Di Taranto,Doan-Loi Do,Ronen Durst,Jana Dvorakova,Christoph F. Ebenbichler,Avishay Elis,Sameh Emil,Marat V. Ezhov,Akl C. Fahed,Tommaso Fasano,Claudio Ferri,Federica Fogacci,Elena Formisano,Giuliana Fortunato,Gordon A. Francis,Tomas Freiberger,Federica Galimberti,Isabel M. Gaspar,Jacques Genest,Marco Gentile,Antonina Giammanco,Cumali Gokce,Susanne Greber-Platzer,Liliana Grigore,Urh Groselj,Mariko Harada-Shiba,Merel L. Hartgers,Robert A. Hegele,Pavel Horak,Mika Hori,Lisa C. Hudgins,Osama Hussein,Gabriella Iannuzzo,Osman Ilhan,Lorenzo Iughetti,Meral Kayikcioglu,Leyla G. Kaynar,Brooke A. Kennedy,Weerapan Khovidhunkit,Genovefa Kolovou,Melis Kose,Irfan Kuku,Erdal Kurtoglu,Katarina S. Lalic,Hong-An Le,Thanh-Tung Le,Eran Leitersdorf,Evangelos Liberopoulos,Alexander R.M. Lyons,Ramón Madriz,Giuseppe Mandraffino,Martin Mäser,Roopa Mehta,Olena Mitchenko,Giuliana Mombelli,Tiziana Montalcini,Carmela Morace,Elie M. Moubarak,Sandro Muntoni,Tarek A. Naguib,Fabio Nascimbeni,Hapizah Nawawi,Georges Nemer,Mai-Ngoc T. Nguyen,Serena Notargiacomo,Harika Okutan,Osman I. Ozcebe,Jing Pang,Angelina Passaro,Chiara Pavanello,Lorenzo Pecchioli,Valerio Pecchioli,Cristina Pederiva,Zafer Pekkolay,Fabio Pellegatta,Salvatore Piro,Matteo Pirro,Livia Pisciotta,Arturo Pujia,Kausik K. Ray,Ashraf Reda,M. Doortje Reijman,Željko Reiner,Sabah H. Rhadi,Luigi Rizzi,Alessandra Romandini,Isabelle Ruel,Daisy Rymen,Fouzia Sadiq,Saim Sag,Osman Z. Salcioglu,Raul D. Santos,Juana M. Sanz,Riccardo Sarzani,Francesco Sbrana,Daniel Schurr,Roberto Scicali,Nitika Setia,Foaad K. Shaghee,Aleksandr Shek,Mark H. Sherman,Vladimir Soska,Christophe A.T. Stevens,Erik S.G. Stroes,Thomas M. Stulnig,Patrizia Suppressa,Andrey V. Susekov,Patrizia Tarugi,Ahmet Temizhan,Lukas Tichy,Chiara Trenti,Tycho R. Tromp,Robin Urbanek,Antonio J. Vallejo-Vaz,helena Vaverkova,Ishwar C. Verma,Michal Vrablik,Luya Wang,Gerald F. Watts,José P. Werba,Albert Wiegman,Peter Witters,Mustafa Yenercag,Mehmet Yilmaz,Hamiyet Yilmaz Yasar,Alberto Zambon,Sabina Zambon,Stanislav Zemek,Maria G. Zenti,Lukas Zlatohlavek,Linda Zuurbier,
DOI: https://doi.org/10.1001/jamacardio.2023.5597
2024-02-14
JAMA Cardiology
Abstract:Importance Homozygous familial hypercholesterolemia (HoFH) is a rare genetic condition characterized by extremely increased low-density lipoprotein (LDL) cholesterol levels and premature atherosclerotic cardiovascular disease (ASCVD). Heterozygous familial hypercholesterolemia (HeFH) is more common than HoFH, and women with HeFH are diagnosed later and undertreated compared to men; it is unknown whether these sex differences also apply to HoFH. Objective To investigate sex differences in age at diagnosis, risk factors, lipid-lowering treatment, and ASCVD morbidity and mortality in patients with HoFH. Design, Setting, and Participants Sex-specific analyses for this retrospective cohort study were performed using data from the HoFH International Clinical Collaborators (HICC) registry, the largest global dataset of patients with HoFH, spanning 88 institutions across 38 countries. Patients with HoFH who were alive during or after 2010 were eligible for inclusion. Data entry occurred between February 2016 and December 2020. Data were analyzed from June 2022 to June 2023. Main Outcomes and Measures Comparison between women and men with HoFH regarding age at diagnosis, presence of risk factors, lipid-lowering treatment, prevalence, and onset and incidence of ASCVD morbidity (myocardial infarction [MI], aortic stenosis, and combined ASCVD outcomes) and mortality. Results Data from 389 women and 362 men with HoFH from 38 countries were included. Women and men had similar age at diagnosis (median [IQR], 13 [6-26] years vs 11 [5-27] years, respectively), untreated LDL cholesterol levels (mean [SD], 579 [203] vs 596 [186] mg/dL, respectively), and cardiovascular risk factor prevalence, except smoking (38 of 266 women [14.3%] vs 59 of 217 men [27.2%], respectively). Prevalence of MI was lower in women (31 of 389 [8.0%]) than men (59 of 362 [16.3%]), but age at first MI was similar (mean [SD], 39 [13] years in women vs 38 [13] years in men). Treated LDL cholesterol levels and lipid-lowering therapy were similar in both sexes, in particular statins (248 of 276 women [89.9%] vs 235 of 258 men [91.1%]) and lipoprotein apheresis (115 of 317 women [36.3%] vs 118 of 304 men [38.8%]). Sixteen years after HoFH diagnosis, women had statistically significant lower cumulative incidence of MI (5.0% in women vs 13.7% in men; subdistribution hazard ratio [SHR], 0.37; 95% CI, 0.21-0.66) and nonsignificantly lower all-cause mortality (3.0% in women vs 4.1% in men; HR, 0.76; 95% CI, 0.40-1.45) and cardiovascular mortality (2.6% in women vs 4.1% in men; SHR, 0.87; 95% CI, 0.44-1.75). Conclusions and Relevance In this cohort study of individuals with known HoFH, MI was higher in men compared with women yet age at diagnosis and at first ASCVD event were similar. These findings suggest that early diagnosis and treatment are important in attenuating the excessive cardiovascular risk in both sexes.
cardiac & cardiovascular systems